Affiliations: [a] Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain | [b] Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain | [c] Department of Biochemistry and Molecular Biology IV, Fac. Veterinary, Complutense University of Madrid, Madrid, Spain | [d] Department of Optics II (Optometry and Vision), Faculty of Optics and Optometry, Complutense University of Madrid, Madrid, Spain
Correspondence:
[*]
Correspondence to: Jesús Avila, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), 28049 Madrid, Spain. Tel.: +34911964564; Fax: +34911964715; E-mail: javila@cbm.uam.es.
Abstract: The pathology associated with tau protein, tauopathy, has been recently analyzed in different disorders, leading to the suggestion that intracellular and extracellular tau may itself be the principal agent in the transmission and spreading of tauopathies. Tau pathology is based on an increase in the amount of tau, an increase in phosphorylated tau, and/or an increase in aggregated tau. Indeed, phosphorylated tau protein is the main component of tau aggregates, such as the neurofibrillary tangles present in the brain of Alzheimer's disease patients. It has been suggested that intracellular tau could be toxic to neurons in its phosphorylated and/or aggregated form. However, extracellular tau could also damage neurons and since neuronal death is widespread in Alzheimer's disease, mainly among cholinergic neurons, these cells may represent a possible source of extracellular tau. However, other sources of extracellular tau have been proposed that are independent of cell death. In addition, several ways have been proposed for cells to interact with, transmit, and spread extracellular tau, and to transduce signals mediated by this tau. In this work, we will discuss the role of extracellular tau in the spreading of the tau pathology.
Keywords: Exomas, muscarinic receptors, phosphotau, tau secretion, tau spreading
